USPTO and FDA Issue Joint Blog on President Biden Executive Order
July 7, 2022
President Biden has signed an executive order to promote competition in the American economy by incentivizing pharmaceutical improvements. Also included in the plan is a call for the USPTO and FDA to leverage collective expertise in promoting innovation and competition to lower prescription drug costs. Learn more.